iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023

Rhea-AI Summary

iSpecimen (Nasdaq: ISPC) has announced that CEO Tracy Curley will participate in the virtual Sequire Biotechnology Conference on February 2, 2023, at 5:00 p.m. ET. The company operates as an online marketplace connecting scientists with healthcare specimen providers for medical research. Interested attendees can register for the conference. iSpecimen utilizes proprietary cloud technology to facilitate searching for human biospecimens across a network of hospitals and labs. For more information about the conference or to arrange a meeting with management, attendees can reach out via email.

LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Sequire Biotechnology Conference to be held virtually on Thursday, February 2, 2023.

Ms. Curley will present at 5:00 p.m. ET. To attend, please register here.

For more information about the conference, or to schedule a one-on-one meeting with iSpecimen’s management team, please contact your appropriate Sequire representative, or send an email to KCSA Strategic Communications at iSpecimen@kcsa.com.

About iSpecimen
iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com.

For further information, please contact:

Investor Contact
KCSA Strategic Communications
Allison Soss
iSpecimen@kcsa.com

Media Contacts
KCSA Strategic Communications
Raquel Cona / Shana Marino
iSpecimen@kcsa.com

FAQ

When will iSpecimen's CEO present at the Sequire Biotechnology Conference?

Tracy Curley, CEO of iSpecimen, will present at the Sequire Biotechnology Conference on February 2, 2023, at 5:00 p.m. ET.

How can I attend the Sequire Biotechnology Conference featuring iSpecimen?

You can register for the Sequire Biotechnology Conference to attend iSpecimen's presentation on February 2, 2023.

What services does iSpecimen provide?

iSpecimen offers an online marketplace connecting scientists with healthcare specimen providers for medical research.

What technology does iSpecimen use to connect scientists and specimen providers?

iSpecimen uses proprietary, cloud-based technology to facilitate specimen searches across a network of healthcare organizations.

How can I contact iSpecimen for more information about the conference?

For more information about the conference, you can email KCSA Strategic Communications at iSpecimen@kcsa.com.